First Trust Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $137M | Buy |
306,461
+105,171
| +52% | +$49M | 0.1% | 253 |
|
|
2025
Q4 | $91.3M | Buy |
201,290
+13,129
| +7% | +$5.66M | 0.07% | 365 |
|
|
2025
Q3 | $73.7M | Sell |
188,161
-99,731
| -35% | -$41.7M | 0.05% | 419 |
|
|
2025
Q2 | $128M | Buy |
287,892
+143,084
| +99% | +$65.9M | 0.1% | 233 |
|
|
2025
Q1 | $70.2M | Sell |
144,808
-47,978
| -25% | -$22.4M | 0.06% | 406 |
|
|
2024
Q4 | $77.6M | Sell |
192,786
-382,246
| -66% | -$177M | 0.07% | 365 |
|
|
2024
Q3 | $267M | Buy |
575,032
+371,691
| +183% | +$179M | 0.25% | 110 |
|
|
2024
Q2 | $95.3M | Sell |
203,341
-27,856
| -12% | -$12.1M | 0.1% | 233 |
|
|
2024
Q1 | $96.6M | Sell |
231,197
-503,638
| -69% | -$213M | 0.1% | 235 |
|
|
2023
Q4 | $299M | Sell |
734,835
-63,531
| -8% | -$23.5M | 0.33% | 52 |
|
|
2023
Q3 | $278M | Buy |
798,366
+508,389
| +175% | +$178M | 0.33% | 50 |
|
|
2023
Q2 | $102M | Sell |
289,977
-42,809
| -13% | -$14.4M | 0.12% | 219 |
|
|
2023
Q1 | $105M | Sell |
332,786
-17,185
| -5% | -$5.15M | 0.12% | 219 |
|
|
2022
Q4 | $101M | Sell |
349,971
-10,921
| -3% | -$3.33M | 0.12% | 231 |
|
|
2022
Q3 | $104M | Sell |
360,892
-668,540
| -65% | -$192M | 0.14% | 188 |
|
|
2022
Q2 | $290M | Buy |
1,029,432
+588,620
| +134% | +$158M | 0.36% | 46 |
|
|
2022
Q1 | $115M | Sell |
440,812
-80,615
| -15% | -$19.1M | 0.12% | 214 |
|
|
2021
Q4 | $115M | Buy |
521,427
+30,756
| +6% | +$5.98M | 0.11% | 219 |
|
|
2021
Q3 | $89M | Buy |
490,671
+91,357
| +23% | +$17.8M | 0.1% | 263 |
|
|
2021
Q2 | $80.5M | Buy |
399,314
+11,734
| +3% | +$2.45M | 0.09% | 303 |
|
|
2021
Q1 | $83.3M | Sell |
387,580
-16,439
| -4% | -$3.61M | 0.1% | 258 |
|
|
2020
Q4 | $95.5M | Sell |
404,019
-425,744
| -51% | -$97.7M | 0.13% | 200 |
|
|
2020
Q3 | $226M | Buy |
829,763
+17,708
| +2% | +$4.89M | 0.36% | 48 |
|
|
2020
Q2 | $236M | Buy |
812,055
+316,633
| +64% | +$85.8M | 0.41% | 36 |
|
|
2020
Q1 | $118M | Buy |
495,422
+138,446
| +39% | +$31.8M | 0.27% | 66 |
|
|
2019
Q4 | $78.2M | Sell |
356,976
-89,458
| -20% | -$18.1M | 0.13% | 188 |
|
|
2019
Q3 | $75.6M | Sell |
446,434
-221,798
| -33% | -$39.2M | 0.14% | 177 |
|
|
2019
Q2 | $123M | Sell |
668,232
-69,332
| -9% | -$12.1M | 0.23% | 86 |
|
|
2019
Q1 | $136M | Buy |
737,564
+29,086
| +4% | +$5.37M | 0.27% | 63 |
|
|
2018
Q4 | $117M | Sell |
708,478
-9,977
| -1% | -$1.73M | 0.28% | 57 |
|
|
2018
Q3 | $138M | Buy |
718,455
+204,780
| +40% | +$36.5M | 0.26% | 64 |
|
|
2018
Q2 | $87.3M | Buy |
513,675
+36,704
| +8% | +$5.69M | 0.18% | 110 |
|
|
2018
Q1 | $77.7M | Sell |
476,971
-65,461
| -12% | -$10.7M | 0.18% | 108 |
|
|
2017
Q4 | $81.3M | Sell |
542,432
-12,589
| -2% | -$1.86M | 0.19% | 95 |
|
|
2017
Q3 | $84.4M | Sell |
555,021
-91,518
| -14% | -$13.8M | 0.22% | 93 |
|
|
2017
Q2 | $83.3M | Buy |
646,539
+243,153
| +60% | +$29.3M | 0.22% | 86 |
|
|
2017
Q1 | $44.1M | Sell |
403,386
-13,906
| -3% | -$1.22M | 0.12% | 172 |
|
|
2016
Q4 | $30.7M | Buy |
417,292
+57,019
| +16% | +$4.64M | 0.09% | 267 |
|
|
2016
Q3 | $31.4M | Sell |
360,273
-56,288
| -14% | -$5.32M | 0.09% | 256 |
|
|
2016
Q2 | $35.8M | Sell |
416,561
-17,404
| -4% | -$1.5M | 0.11% | 200 |
|
|
2016
Q1 | $34.5M | Sell |
433,965
-545,760
| -56% | -$49.4M | 0.11% | 213 |
|
|
2015
Q4 | $123M | Sell |
979,725
-43,619
| -4% | -$5.27M | 0.32% | 54 |
|
|
2015
Q3 | $107M | Buy |
1,023,344
+22,220
| +2% | +$2.85M | 0.31% | 64 |
|
|
2015
Q2 | $124M | Buy |
1,001,124
+150,498
| +18% | +$19M | 0.32% | 53 |
|
|
2015
Q1 | $100M | Sell |
850,626
-165,610
| -16% | -$19.8M | 0.29% | 62 |
|
|
2014
Q4 | $121M | Buy |
1,016,236
+133,010
| +15% | +$15M | 0.41% | 26 |
|
|
2014
Q3 | $99.2M | Sell |
883,226
-102,926
| -10% | -$9.8M | 0.39% | 28 |
|
|
2014
Q2 | $93.4M | Buy |
986,152
+198,579
| +25% | +$13.9M | 0.39% | 22 |
|
|
2014
Q1 | $55.7M | Buy |
787,573
+153,849
| +24% | +$12.2M | 0.24% | 60 |
|
|
2013
Q4 | $47.1M | Sell |
633,724
-26,782
| -4% | -$1.87M | 0.23% | 70 |
|
|
2013
Q3 | $50.1M | Buy |
660,506
+252,451
| +62% | +$20.1M | 0.27% | 55 |
|
|
2013
Q2 | $32.7M | Buy |
+408,055
| New | +$30.1M | 0.21% | 92 |
|
Other funds holding VRTX
VCM
VPM
First Trust Advisors's VRTX Position: Q1 2026 in Review
First Trust Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 52% in Q1 2026, buying an estimated $49M and bringing the position to 306,461 shares worth $137M. The position accounts for 0.1% of the portfolio, ranked #253.
First Trust Advisors first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $299M in Q4 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- First Trust Advisors held 306,461 shares of Vertex Pharmaceuticals worth $137M as of Q1 2026.
- First Trust Advisors bought 105,171 Vertex Pharmaceuticals shares in Q1 2026, an estimated $49M.
- Vertex Pharmaceuticals made up 0.1% of First Trust Advisors's portfolio in Q1 2026, its #253 holding.
- First Trust Advisors first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- First Trust Advisors's Vertex Pharmaceuticals position peaked at $299M in Q4 2023.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.